Overview

Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if varenicline is effective in treating symptoms of Friedreich's ataxia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of South Florida
Collaborators:
Friedreich's Ataxia Research Alliance
Pfizer
Treatments:
Varenicline